Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA response to the monkeypox public health emergency 27 Ιούλιος 2022NewsHumanMpoxMedicines Hydroxyethyl-starch solutions for infusion recommended for suspension from the market 26 Ιούλιος 2022NewsHumanPharmacovigilance EMA Paediatric Committee elects Brian Aylward as its new Chair 25 Ιούλιος 2022NewsHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2022 22 Ιούλιος 2022NewsHumanCOVID-19MpoxMedicines New medicine for multiple myeloma patients with limited treatment options 22 Ιούλιος 2022NewsHumanMedicines EMA recommends restricting use of cancer medicine Rubraca 22 Ιούλιος 2022NewsHumanMedicinesReferrals EMA recommends approval of Imvanex for the prevention of monkeypox disease 22 Ιούλιος 2022NewsHumanMpoxMedicines Global regulators call for international collaboration to integrate real-world evidence into regulatory decision-making 22 Ιούλιος 2022NewsHuman Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-14 July 2022 15 Ιούλιος 2022NewsVeterinaryMedicines Towards better prevention of medicine shortages in the EU 15 Ιούλιος 2022NewsHumanMedicine shortages 1 … 42 43 44 45 46 Page 46 of 384 47 48 49 50 … 384
Hydroxyethyl-starch solutions for infusion recommended for suspension from the market 26 Ιούλιος 2022NewsHumanPharmacovigilance
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2022 22 Ιούλιος 2022NewsHumanCOVID-19MpoxMedicines
New medicine for multiple myeloma patients with limited treatment options 22 Ιούλιος 2022NewsHumanMedicines
EMA recommends approval of Imvanex for the prevention of monkeypox disease 22 Ιούλιος 2022NewsHumanMpoxMedicines
Global regulators call for international collaboration to integrate real-world evidence into regulatory decision-making 22 Ιούλιος 2022NewsHuman
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-14 July 2022 15 Ιούλιος 2022NewsVeterinaryMedicines